Sudden discontinuation of chronic high dose intrathecal hydromorphone and its withdrawal implications
Costello, K.; Brancolini, S.
Pain Physician 18(1): E75-E77
2015
ISSN/ISBN: 2150-1149 PMID: 25675074 Document Number: 682331
Document emailed within 1 workday
Related Documents
Maskatia, Z.K.; Koo, J. 2007: Rebound of psoriasis after efalizumab discontinuation, despite being on high-dose cyclosporine Journal of Drugs in Dermatology: Jdd 6(9): 941-944Leblanc, T.; Chevallier, B.; Doz, F.; Wood, C.; Lagardère, B.; Bastian, G.; Ladjabi, A. 1987: Inadvertent intrathecal injection of a high dose of methotrexate. Proposal of a therapeutic plan apropos of a case Annales de Pediatrie 34(6): 453-454
Armenta, D.; Espallargas, C.; Paz, A.; Rodríguez Martorel, J.; Ladines, R.; Alvarez, C.; Román, J.; Andrés, P. 1996: Complete cytogenetic remission of chronic myeloid leukemia with low-dose interferon alfa-2b and monthly high-dose busulfan Sangre 41(6): 465-467
Smith, T.R.; Mithal, D.S.; Park, A.; Bohnen, A.; Adel, J.; Rosenow, J.M. 2013: Emergent intrathecal baclofen withdrawal after pseudomeningocele aspiration Pain Physician 16(2): E113-E118
D'Aleo, G.; Cammaroto, S.; Rifici, C.; Marra, G.; Sessa, E.; Bramanti, P.; Di Bella, P. 2007: Hallucinations after abrupt withdrawal of oral and intrathecal baclofen Functional Neurology 22(2): 81-88
Ertem, D.; Acar, Y.şi.; Kotiloğlu Karaa, E.; Pehlivanoğlu, E. 2003: High-dose interferon results in high HBsAg seroclearance in children with chronic hepatitis B infection Turkish Journal of Pediatrics 45(2): 123-128
Stetkarova, I.; Brabec, K.; Vasko, P.; Mencl, L. 2015: Intrathecal Baclofen in Spinal Spasticity: Frequency and Severity of Withdrawal Syndrome Pain Physician 18(4): E633-E641
Bianchi, M.; Musch, B. 1990: Zopiclone discontinuation: review of 25 studies assessing withdrawal and rebound phenomena International Clinical Psychopharmacology 5(Suppl 2): 139-145
Al-Khodairy, A.T.; Vuagnat, H.; Uebelhart, D. 1999: Symptoms of recurrent intrathecal baclofen withdrawal resulting from drug delivery failure: a case report American Journal of Physical Medicine and Rehabilitation 78(3): 272-277
Thomas, H.C. 1989: Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers: implications for the treatment of chronic HBV carriers Quarterly Journal of Medicine 73(270): 873-874
Liebaldt, G.P. 1973: Can the high relapse-quote after withdrawal-treatments by means of chronic alcoholism also neurophysiologically, physiologic-chemically and especially cerebral-pathologically be substantiated? Fortschritte der Neurologie Psychiatrie und Ihrer Grenzgebiete 41(8): 449-461
Storm-Mathisen, H. 1973: The danger of sudden withdrawal of Catapresan Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(29): 2172-2173
Capizzi, R.L.; Powell, B.L. 1987: Sequential high-dose ara-C and asparaginase versus high-dose ara-C alone in the treatment of patients with relapsed and refractory acute leukemias Seminars in Oncology 14(2 Suppl 1: 40-50
Arlin, Z.A.; Feldman, E.J.; Finger, L.R.; Ahmed, T.; Mittelman, A.; Cook, P.; Puccio, C.; Baskind, P.; Arnold, P.; Razis, E.D. 1991: Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia Leukemia 5(8): 712-714
Bowen, D.; Southerland, W.M.; Johnson, D.H.; Hawkins, M.; Hughes, D.E. 2000: Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells Cancer Detection and Prevention 24(5): 452-458
Halawa, B. 1981: Complications associated with sudden withdrawal of various drugs used in the treatment of cardiovascular diseases Wiadomosci Lekarskie 34(6): 491-495
Brodkey, J.A.; Feler, C.A. 1993: Hypotension following a trial intrathecal dose of baclofen Journal of the Tennessee Medical Association 86(7): 297-298
Techapaitoon, S. 1999: Efficacy of high dose interferon--alpha treatment of chronic hepatitis B Journal of the Medical Association of Thailand 82(11): 1118-1126
Blatt, J.; Howrie, D.L.; Wollman, M.R.; Phebus, C.; Mirro, J. 1993: Toxicity following concurrent intrathecal and moderate-dose intravenous methotrexate Leukemia 7(11): 1734-1737
Rodanant, O.; Sirichotewithayakorn, P.; Sriprajittichai, P.; Charuluxananan, S. 2003: An optimal dose study of intrathecal morphine in gynecological patients Journal of the Medical Association of Thailand 86(Suppl): S331-S337